基于电子健康记录的胰腺癌风险模型开发与验证
本研究利用波士顿两家医院1979至2017年的电子健康记录数据,采用病例对照匹配,开发并验证了胰腺导管腺癌风险预测模型。逻辑回归模型在诊断前365天的验证集中AUC为0.68,数据驱动特征选择优于基线模型,高危组癌症发生率是数据集患病率的3至5倍。该简便EHR模型可提前一年识别高危个体,有望作为胰腺癌筛查的第一道筛选工具。
要点
- 逻辑回归EHR模型在诊断前365天验证集AUC为0.68。
- 数据驱动特征选择优于手工选择诊断的基线模型。
- 高危组癌症发生率是数据集患病率的3至5倍。
核心结论
- 基于诊断信息的简单EHR模型可提前一年识别胰腺导管腺癌高危个体。
研究设计与样本
- 观察性研究,使用波士顿两家独立医院1979至2017年电子健康记录数据库,采用病例对照匹配。
- 训练集包含594例病例和100787例对照,验证集包含408例病例和160185例对照。
- 开发神经网络和L2正则化逻辑回归模型,并与基于手工选择诊断的已发表基线模型比较。
- 考虑180天、270天和365天三个预测提前时间。
主要发现
- 风险分层显示高危组癌症发生率是数据集患病率的3至5倍。
临床怎么用
- 该低成本系统化方法或可作为胰腺癌筛查项目选择个体的第一道筛选工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed at a late, incurable stage. We sought to determine whether individuals at high risk of developing PDAC could be identified early using routinely collected data. METHODS: Electronic health record (EHR) databases from two independent hospitals in Boston, Massachusetts, providing inpatient, outpatient, and emergency care, from 1979 through 2017, were used with case-control matching. PDAC cases were selected using International Classification of Diseases 9/10 codes and validated with tumour registries. A data-driven feature selection approach was used to develop neural networks and L2-regularised logistic regression (LR) models on training data (594 cases, 100,787 controls) and compared with a published model based on hand-selected diagnoses ('baseline'). Model performance was validated on an external database (408 cases, 160,185 controls). Three prediction lead times (180, 270 and 365 days) were considered. RESULTS: The LR model had the best performance, with an area under the curve (AUC) of 0.71 (confidence interval [CI]: 0.67-0.76) for the training set, and AUC 0.68 (CI: 0.65-0.71) for the validation set, 365 days before diagnosis. Data-driven feature selection improved results over 'baseline' (AUC = 0.55; CI: 0.52-0.58). The LR model flags 2692 (CI 2592-2791) of 156,485 as high risk, 365 days in advance, identifying 25 (CI: 16-36) cancer patients. Risk stratification showed that the high-risk group presented a cancer rate 3 to 5 times the prevalence in our data set. CONCLUSION: A simple EHR model, based on diagnoses, can identify high-risk individuals for PDAC up to one year in advance. This inexpensive, systematic approach may serve as the first sieve for selection of individuals for PDAC screening programs.
引用
- Appelbaum L, Cambronero JP, Stevens JP, et al. Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study. Eur J Cancer. 2020. PMID: 33278770. doi:10.1016/j.ejca.2020.10.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。